Danske Bank
OBX icon

Danske Bank’s Obsidian Therapeutics OBX Stock Holding History

Danske Bank’s Portfolio OBX Stock Details OBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$14 Buy
+1
New +$20 ﹤0.01% 1060

Other funds holding OBX

Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Revelation Capital Management
Revelation Capital Management Sausalito, California $8.01M AUM 49.3% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Danske Bank's OBX Position: Q3 2026 in Review

Danske Bank opened a new position in Obsidian Therapeutics (OBX) in Q3 2026: 1 share worth $14. The stake represents ﹤0.01% of the portfolio and ranks #1060 among its holdings.

8 funds tracked by Wall St. Rank hold OBX as of Q3 2026.

  • Danske Bank held 1 share of Obsidian Therapeutics worth $14 as of Q3 2026.
  • Obsidian Therapeutics was a new Danske Bank position in Q3 2026.
  • Obsidian Therapeutics made up ﹤0.01% of Danske Bank's portfolio in Q3 2026, its #1060 holding.
  • 8 funds tracked by Wall St. Rank held Obsidian Therapeutics as of Q3 2026.

Based on Danske Bank's 13F filing for Q3 2026, filed 9 Nov 2026.